As China’s drug industry races ahead, its GLP-1 race is accelerating too Novo Nordisk and Eli Lilly still enjoy advantages, but there could be early cracks in their dominance

https://www.statnews.com/2026/02/17/china-drug-industry-biotech-glp1/ By Brian YangFeb. 17, 2026